Ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoate (BioDeep_00000176220)
human metabolite blood metabolite
代谢物信息卡片
化学式: C26H32O2 (376.2402)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CCOC(=O)C1=CC=C(C=C(C)C2=CC3=C(C=C2)C(C)(C)CCC3(C)C)C=C1
InChI: InChI=1S/C26H32O2/c1-7-28-24(27)20-10-8-19(9-11-20)16-18(2)21-12-13-22-23(17-21)26(5,6)15-14-25(22,3)4/h8-13,16-17H,7,14-15H2,1-6H3
描述信息
同义名列表
7 个代谢物同义名
Ethyl-p-((e)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid; ethyl 4-[2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl]benzoate; Ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoate; ethyl 4-[2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-en-1-yl]benzoate; Ethyl-p-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoate; Arotinoid ethyl ester; Arotinoid ro 136298
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
1 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
| 亚细胞结构定位 | 关联基因列表 |
|---|
文献列表
- L Visentin, R A Dodds, M Valente, P Misiano, J N Bradbeer, S Oneta, X Liang, M Gowen, C Farina. A selective inhibitor of the osteoclastic V-H(+)-ATPase prevents bone loss in both thyroparathyroidectomized and ovariectomized rats.
The Journal of clinical investigation.
2000 Jul; 106(2):309-18. doi:
10.1172/jci6145. [PMID: 10903347] - F Pomponi, R Cariati, P Zancai, P De Paoli, S Rizzo, R M Tedeschi, B Pivetta, S De Vita, M Boiocchi, R Dolcetti. Retinoids irreversibly inhibit in vitro growth of Epstein-Barr virus-immortalized B lymphocytes.
Blood.
1996 Oct; 88(8):3147-59. doi:
10.1182/blood.v88.8.3147.bloodjournal8883147. [PMID: 8874215] - N Vu-Dac, K Schoonjans, V Kosykh, J Dallongeville, R A Heyman, B Staels, J Auwerx. Retinoids increase human apolipoprotein A-11 expression through activation of the retinoid X receptor but not the retinoic acid receptor.
Molecular and cellular biology.
1996 Jul; 16(7):3350-60. doi:
10.1128/mcb.16.7.3350. [PMID: 8668150] - R Mouawad, S Urien, C Soubrane, D Khayat, R Brandt, J P Tillement, G Bastian. Comparison of the uptake of retinoids 13-cis-retinoic acid and Ro 13-6298 delivered to HL-60 cells by serum albumin or low-density lipoprotein.
Cancer chemotherapy and pharmacology.
1996; 38(2):198-201. doi:
10.1007/s002800050471. [PMID: 8616913] - R C Mühlbauer, F Bauss, R Schenk, M Janner, E Bosies, K Strein, H Fleisch. BM 21.0955, a potent new bisphosphonate to inhibit bone resorption.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
1991 Sep; 6(9):1003-11. doi:
10.1002/jbmr.5650060915. [PMID: 1838661] - C C Willhite, R P Sharma, P V Allen, D L Berry. Percutaneous retinoid absorption and embryotoxicity.
The Journal of investigative dermatology.
1990 Nov; 95(5):523-9. doi:
10.1111/1523-1747.ep12504873. [PMID: 2230214] - U Trechsel, A Stutzer, H Fleisch. Hypercalcemia induced with an arotinoid in thyroparathyroidectomized rats. New model to study bone resorption in vivo.
The Journal of clinical investigation.
1987 Dec; 80(6):1679-86. doi:
10.1172/jci113257. [PMID: 3680521] - A Vahlquist, O Rollman. Clinical pharmacology of 3 generations of retinoids.
Dermatologica.
1987; 175 Suppl 1(?):20-7. doi:
10.1159/000248850. [PMID: 3319726] - Y Mérot, M Camenzind, J M Geiger, J H Saurat. Arotinoid ethyl ester (Ro 13-6298): a long term pilot study in various dermatoses.
Acta dermato-venereologica.
1987; 67(3):237-42. doi:
NULL. [PMID: 2442937]
